Health Care & Life Sciences » Biotechnology | Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG | Ownership

Companies that own Santhera Pharmaceuticals Holding AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
RTW Investments LP
315,339
4.83%
0
0.32%
12/31/2017
Lagoda Investment Management LP
187,888
2.88%
0
1.01%
11/10/2017
Norges Bank Investment Management
128,398
1.97%
2,628
0%
01/31/2018
UBS AG (Investment Management)
97,449
1.49%
-13,700
0%
09/04/2018
Credit Suisse Asset Management (Schweiz) AG
48,127
0.74%
-577
0%
05/31/2018
Rieter Fischer Partners AG
43,352
0.66%
0
0.26%
08/31/2018
Zürcher Kantonalbank (Investment Management)
38,780
0.59%
124
0%
07/31/2018
Privatbank Von Graffenried AG
14,020
0.22%
-1,680
0.08%
11/30/2017
Pictet Asset Management SA
13,906
0.21%
0
0%
03/31/2018
Crossinvest SA
8,400
0.13%
-41,600
0.06%
12/31/2017

About Santhera Pharmaceuticals Holding

View Profile
Address
Hohenrainstrasse 24
Pratteln Basel-Landschaft (Basle Country) 4133
Switzerland
Employees -
Website http://www.santhera.com
Updated 07/08/2019
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.